Published in Arch Dermatol on June 01, 1990
Management of alopecia areata. BMJ (2010) 1.25
Alopecia areata: a new treatment plan. Clin Cosmet Investig Dermatol (2011) 0.82
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC Dermatol (2005) 0.81
Extensive alopecia areata: not necessarily recalcitrant to therapy! Int J Trichology (2011) 0.78
Alopecia areata: Part 2: treatment. Can Fam Physician (2015) 0.77
Papulonecrotic tuberculid secondary to disseminated Mycobacterium avium complex. Int J Dermatol (1994) 1.40
The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax (2008) 1.35
Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. J Immunol (1983) 1.11
Cutaneous myiasis due to Dermatobia hominis. Arch Dermatol (1977) 1.06
Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum (2001) 1.03
Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships. Clin Pharmacol Ther (1983) 1.02
Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships. Biopharm Drug Dispos (1987) 0.97
[Efficacy and safety of mouthwash diclofenac in oral or periodontal surgery]. Minerva Stomatol (2001) 0.96
Pathological false alarm rates following damage to the left frontal cortex. Brain Cogn (1996) 0.96
The EuroPrevall surveys on the prevalence of food allergies in children and adults: background and study methodology. Allergy (2009) 0.87
Extended Hildebrand solubility approach: testosterone and testosterone propionate in binary solvents. J Pharm Sci (1982) 0.85
Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide. Ann Rheum Dis (2005) 0.85
Gastrointestinal transit of nondisintegrating, nonerodible oral dosage forms in pigs. Pharm Res (1990) 0.84
Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study. Clin Ther (1998) 0.84
Does sexual coercion play a role in the high-risk sexual behavior of adolescent and young adult women? J Behav Med (1995) 0.83
[Churg-Strauss syndrome--recent developments in diagnosis and treatment]. Dtsch Med Wochenschr (2006) 0.82
Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input. Biopharm Drug Dispos (1985) 0.82
Pharmacokinetics of ibuprofen in man--III: Plasma protein binding. J Pharmacokinet Biopharm (1983) 0.82
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). Lupus (2013) 0.82
Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.82
Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clin Pharmacol Ther (1990) 0.80
Multiclinic double-blind comparison of triazolam and flurazepam for seven nights in outpatients with insomnia. J Clin Pharmacol (1977) 0.80
Absorption of flurbiprofen in the fed and fasted states. Pharm Res (1992) 0.79
Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. JAMA (1975) 0.79
Pharmacokinetics of ibuprofen in man IV: absorption and disposition. J Pharmacokinet Biopharm (1984) 0.79
Skin resurfacing utilizing a low-fluence Nd:YAG laser. J Cutan Laser Ther (1999) 0.78
Pharmacokinetics of spectinomycin in volunteers with renal insufficiency. Chemotherapy (1981) 0.78
Streptococcal adherence to Langerhans cells: a possible step in the pathogenesis of streptococcal pharyngitis. Clin Immunol Immunopathol (1994) 0.77
Oral isotretinoin therapy for familial Muir-Torre syndrome. J Am Acad Dermatol (1985) 0.76
Arbaprostil (15(R)-15-methyl PGE2): lack of effect on theophylline metabolism. Br J Clin Pharmacol (1986) 0.75
Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution. J Pharm Sci (1990) 0.75
Estimation of the life span of red blood cells in the growing animal in different nutritional states. J Gen Physiol (1965) 0.75
Absence of cardiac arrhythmias during a very-low-calorie diet with high biological quality protein. Int J Obes (1983) 0.75
Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model. Drug Metab Dispos (1984) 0.75
Bacillary angiomatosis of the skin and bone marrow in a patient with HIV infection. J Am Acad Dermatol (1995) 0.75
[Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients]. Z Rheumatol (2004) 0.75
Disseminated cutaneous granulomas from BCG therapy. Arch Dermatol (1980) 0.75
Single dose and steady-state pharmacokinetics of adinazolam after oral administration to man. Biopharm Drug Dispos (1987) 0.75
[Hygiene courses in Ticino. Interview by Ercole Gusberti]. Schweiz Monatsschr Zahnmed (1995) 0.75
[The Bone Symposium Bern, 11-12 December 1999]. Schweiz Monatsschr Zahnmed (2000) 0.75
Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia. J Clin Psychiatry (1978) 0.75
[21-year-old female patient with oral aphthosis and skin lesions]. Dtsch Med Wochenschr (2011) 0.75
Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets. Biopharm Drug Dispos (1989) 0.75
Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon {alpha}. Ann Rheum Dis (2005) 0.75
Symmetrical enlargement of breasts and testes due to leukemic infiltration. South Med J (1972) 0.75
[Position of deep cerebral veins in healthy persons and tumor patients (contribution to the problem of mirrorimage symmetry in normal cerebral veins)]. Radiologe (1971) 0.75
Treatment of ragweed hay fever with flurbiprofen, a cyclooxygenase-inhibiting drug. Ann Allergy (1985) 0.75
Attenuation of protection with repeated cromolyn dosing before exercise challenge in subjects with asthma. J Clin Pharmacol (1986) 0.75
Practical ENT. Incidence of palpable cervical nodes in adults. Postgrad Med (1977) 0.75
Evaluation of oral minoxidil in the treatment of alopecia areata. Arch Dermatol (1987) 0.75
Enzymology, with applications to dermatology. Int J Dermatol (1981) 0.75
[Amalgam--a question of belief? A review and assessment of the current literature]. Schweiz Monatsschr Zahnmed (1998) 0.75
[New orthodontic treatment possibilities with Orthosystem implants. The 1st Orthosystem course at the University of Bern]. Schweiz Monatsschr Zahnmed (1998) 0.75
Absorption of minoxidil after topical application: effect of frequency and site of application. Clin Pharmacol Ther (1989) 0.75
Male Turner's syndrome: a case report with normal external genitalia, hormonal assays and secondary sex characteristics. Mil Med (1970) 0.75
Effect of flurbiprofen, a cyclooxygenase inhibiting drug, on induced allergic rhinitis. J Allergy Clin Immunol (1984) 0.75
Drug combinations quick reference guide. Res Initiat Treat Action (2000) 0.75
Correlation of ibuprofen bioavailability with gastrointestinal transit by scintigraphic monitoring of 171Er-labeled sustained-release tablets. Pharm Res (1987) 0.75
Congenital unilateral punctate porokeratosis. Am J Dermatopathol (1984) 0.75
Sepsis associated with Norwegian scabies in patients with acquired immunodeficiency syndrome. Cutis (1992) 0.75
Effect of H2 blockade in the challenged allergic nose. J Allergy Clin Immunol (1982) 0.75
Androgenetic alopecia. Arch Dermatol (1990) 0.75
Skin moisturization without occlusion. Cutis (1981) 0.75
[Lateral alveolar ridge augmentation in implantology. A report on the GBR-Master's Course in Waldenburg of 22 September 1995]. Schweiz Monatsschr Zahnmed (1996) 0.75
A nonlinear physiologic pharmacokinetic model: I. Steady-state. J Pharmacokinet Biopharm (1985) 0.75